Soleus Capital Management, L.P. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.18 Billion distributed in 87 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Iovance Biotherapeutics, Inc. with a value of $80.1M, Tg Therapeutics, Inc. with a value of $59.3M, Terns Pharmaceuticals, Inc. with a value of $51.9M, Axogen, Inc. with a value of $42.1M, and Grifols Sa with a value of $40.2M.
Examining the 13F form we can see an increase of $190M in the current position value, from $987M to 1.18B.
Soleus Capital Management, L.P. is based out at Greenwich, CT
Below you can find more details about Soleus Capital Management, L.P. portfolio as well as his latest detailed transactions.
